Key Insights

Highlights

Success Rate

50% trial completion

Treatment Research

8 treatments under study, led by Low Glucose Predictive Suspend System

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 80/100

Termination Rate

33.3%

1 terminated out of 3 trials

Success Rate

50.0%

-36.6% vs benchmark

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

50% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (2)
Phase 4 (1)

Trial Status

Completed1
Not Yet Recruiting1
Terminated1

Trial Success Rate

50.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT06729892Phase 4Not Yet Recruiting

Feasibility of Closed-loop TCI Based on New EEG Baseline in the Presence of Low Dose of Esketamine

NCT04042207Not ApplicableCompleted

Diabeloop for Highly Unstable Type 1 Diabetes

NCT04190277Not ApplicableTerminated

Safety Assessment of DBLUS System in Adolescent and Adult Patients With Type 1 Diabetes and Assessment of Its Clinical Efficacy (DIABELOOP SP8)

Showing all 3 trials

Research Network

Common Treatments

  • Low Glucose Predictive Suspend System1
  • Openloop Condition1
  • Dblhu System1
  • Esketamine1
  • An Equivalent Dose Of Saline1

Active Sponsors

  • Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète2
  • bo xu1

Top Investigators

Related Conditions

  • Diabetes Mellitus Type 12
  • Diabetes Mellitus Brittle1
  • General Anesthesia With Propofol1

Activity Timeline